Latest news
Loading news…
Scioderm
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Durham, North Carolina, United States Founded 2012 11-50 employees For Profit
Scioderm, a clinical stage pharmaceutical company, develops topical products for the treatment of chronic skin diseases.
Scioderm was acquired by Amicus Therapeutics in 2015 for $847M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
7
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Patents granted
- 7
- Trademarks
- 0
- Top patent class
- a61
- IT spend
- $13.76M
Company Info
- Founded
- 2012
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 12
- HQ
- Durham, North Carolina, United States
- Region
- Research Triangle, East Coast, Southern US
- Exit date
- Aug 31, 2015
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -1.5
- Trend (90d)
- -0.2
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Scioderm
Loading news…
FAQs about Scioderm
People who checked this page also checked these
Browse the full Acquirezy directory.